Skip to main content
    K

    KORU Medical Systems, Inc. (KRMD)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $3.69
    -0.01 (-0.27%)

    Market Cap: $160.49M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    KORU Medical Systems, Inc. (KRMD) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    KORU Medical Systems (KRMD) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, KORU Medical Systems reported EPS of $0.02, above the -$0.02 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    61%(19/31)
    Avg Surprise
    +36.34%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.01
    Range-$0.01 - $0.00
    6 analysts
    Revenue Consensus
    $12.81M
    Range$11.34M - $13.83M
    6 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    2 analysts
    EPS RevisionsNo revisions (30d)
    Revenue Consensus
    $13.57M
    Range$13.00M - $13.89M
    4 analysts

    Next Report

    KRMD has an expected report date of Mar 10, 2027.

    KRMD Earnings Call

    The latest KRMD earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 31 quarters below that had an estimate, KRMD beat 19, missed 4 and matched 8. Revenue for the quarter ended Sep 30, 2026 was $11.57M, up 11.3% from $10.40M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.02-$0.02-$0.02 - -$0.02+200.00%BeatN/A20 up, 1 downNov 10, 2026$11.57M
    Jun 30, 2026$0.01-$0.02N/A+150.00%Beat0.0%20 up, 0 downAug 5, 2026$12.05M
    Mar 31, 2026-$0.02-$0.01-$0.01 - $0.00-100.00%MissN/A20 up, 1 downMay 6, 2026$11.76M
    Dec 31, 2025$0.01-$0.02-$0.02 - $0.00+155.56%BeatN/A40 up, 0 downMar 12, 2026$10.90M
    Sep 30, 2025-$0.02-$0.02-$0.03 - -$0.02+16.00%BeatN/A40 up, 1 downNov 12, 2025$10.40M
    Jun 30, 2025$0.01-$0.02-$0.03 - -$0.01+150.00%BeatN/A41 up, 0 downAug 6, 2025$10.19M
    Mar 31, 2025-$0.03-$0.03-$0.03 - -$0.020.00%In lineN/A41 up, 1 downMay 7, 2025$9.64M
    Dec 31, 2024-$0.03-$0.03-$0.03 - -$0.010.00%In lineN/A32 up, 0 downMar 12, 2025$8.84M
    Sep 30, 2024-$0.01-$0.04-$0.05 - -$0.03+75.00%BeatN/A50 up, 0 downNov 13, 2024$8.18M
    Jun 30, 2024-$0.01-$0.04-$0.05 - -$0.04+75.00%BeatN/A50 up, 0 downAug 7, 2024$8.43M
    Mar 31, 2024-$0.02-$0.04-$0.05 - -$0.03+50.00%BeatN/A50 up, 0 downMay 1, 2024$8.20M
    Dec 31, 2023-$0.03-$0.04-$0.06 - -$0.02+25.00%BeatN/A50 up, 0 downMar 13, 2024$7.19M
    Sep 30, 2023-$0.03-$0.05-$0.06 - -$0.03+40.00%BeatN/A50 up, 0 downNov 8, 2023$7.00M
    Jun 30, 2023-$0.05-$0.06-$0.06 - -$0.05+16.67%BeatN/A30 up, 1 downAug 9, 2023$6.94M
    Mar 31, 2023-$0.05-$0.05-$0.06 - -$0.040.00%In lineN/A31 up, 0 downMay 4, 2023$7.39M
    Dec 31, 2022-$0.04-$0.06-$0.06 - -$0.05+33.33%BeatN/A30 up, 0 downMar 8, 2023$7.34M
    Sep 30, 2022-$0.03-$0.05-$0.06 - -$0.05+40.00%BeatN/A30 up, 0 downNov 9, 2022$7.76M
    Jun 30, 2022-$0.06-$0.06-$0.08 - -$0.060.00%In lineN/A30 up, 0 downAug 3, 2022$6.55M
    Mar 31, 2022-$0.05-$0.06-$0.06 - -$0.05+16.67%BeatN/A30 up, 0 downMay 4, 2022$6.24M
    Dec 31, 2021-$0.02-$0.03-$0.05 - -$0.02+33.33%BeatN/A30 up, 0 downMar 2, 2022$6.49M
    Sep 30, 2021-$0.02-$0.02-$0.03 - -$0.010.00%In line-300.0%3N/ANov 10, 2021$6.04M
    Jun 30, 2021-$0.02-$0.02-$0.03 - -$0.010.00%In line-166.7%3N/AAug 11, 2021$5.53M
    Mar 31, 2021-$0.03-$0.01-$0.01 - $0.00-200.00%Miss-400.0%3N/AMay 12, 2021$5.43M
    Dec 31, 2020-$0.02-$0.01-$0.02 - $0.01-100.00%Miss-300.0%3N/AMar 23, 2021$4.06M
    Sep 30, 2020$0.01$0.02$0.02 - $0.02-50.00%Miss-75.0%4N/ANov 3, 2020$6.08M
    Jun 30, 2020$0.03$0.02$0.02 - $0.02+50.00%Beat0.0%3N/AAug 4, 2020$7.71M
    Mar 31, 2020$0.01$0.01$0.01 - $0.010.00%In line-50.0%1N/AMay 4, 2020$6.33M
    Dec 31, 2019$0.01$0.01N/A0.00%In line-66.7%N/AN/AFeb 25, 2020$6.22M
    Sep 30, 2019$0.04$0.01N/A+300.00%Beat+300.0%2N/ANov 5, 2019$6.62M
    Jun 30, 2019$0.03$0.02N/A+50.00%Beat+200.0%N/AN/AAug 6, 2019$5.35M
    Mar 31, 2019$0.02$0.01N/A+100.00%Beat+100.0%N/AN/AApr 30, 2019$4.97M
    Dec 31, 2018$0.03N/AN/AN/AN/A+316.7%N/AN/AFeb 12, 2019$4.27M
    Sep 30, 2018$0.01N/AN/AN/AN/A+42.9%N/AN/AOct 23, 2018$4.55M
    Jun 30, 2018$0.01N/AN/AN/AN/AN/AN/AN/AAug 6, 2018$4.50M
    Mar 31, 2018$0.01N/AN/AN/AN/AN/AN/AN/AMay 7, 2018$4.03M
    Dec 31, 2017$0.01N/AN/AN/AN/AN/AN/AN/AFeb 13, 2018$4.66M
    Sep 30, 2017$0.01N/AN/AN/AN/AN/AN/AN/ASep 30, 2017$3.85M
    Jun 30, 2016$0.00N/AN/AN/AN/A-125.0%N/AN/AAug 30, 2016$2.99M
    Mar 31, 2016-$0.01N/AN/AN/AN/AN/AN/AN/AMay 30, 2016$2.99M
    Dec 31, 2015$0.01N/AN/AN/AN/A+15.2%N/AN/AFeb 29, 2016$3.14M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.03, after -$0.07 the year before. It was $0.02 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.03N/A
    Dec 31, 2024-$0.07N/A
    Dec 31, 2023-$0.16N/A
    Dec 31, 2022-$0.18N/A
    Dec 31, 2021-$0.09-400.0%
    Dec 31, 2020$0.03-70.0%
    Dec 31, 2019$0.10N/A
    Dec 31, 2018$0.06+916.9%
    Dec 31, 2017$0.01N/A
    Dec 31, 2015$0.02N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,900 words across 8 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,8588
    2026Q2Jun 30, 20265,3918
    2026Q1Mar 31, 20266,0469
    2025Q4Dec 31, 20256,4849
    2025Q3Sep 30, 20255,7238
    2025Q2Jun 30, 20255,7389
    2025Q1Mar 31, 20256,8859
    2024Q4Dec 31, 20246,7949

    2026Q3 Earnings Call

    Opening remarks

    Louisa Smith Investor Relations Thank you, operator, and good afternoon, everyone. Joining me on the call today are Adam Kalbermatten, President and Chief Executive Officer of KORU Medical Systems, and Tom Adams, Chief Financial Officer. Earlier today, KORU released financial results for the third quarter ended September 30, 2026. A copy of the press release is available on the company's website. I encourage listeners to have our press release in front of them, which includes our financial results and commentary on the quarter. Additionally, we will use slides to support further commentary in today's call, which are also available on the Investor Relations section of our website. During this call, we will make certain forward-looking statements regarding our business plans and other matters. These comments are based on our predictions and expectations as of today. Actual events or results could differ materially due to risks and uncertainties, including those mentioned in the associated press release and our most recent filings with the SEC. We assume no obligation to update any forward-looking statements. During the call, management will also discuss certain non-GAAP financial measures. You'll find additional disclosures, including reconciliations of these non-GAAP measures with comparable GAAP measures in our press release, the accompanying investor presentation, and SEC filings. For the benefit of those listening to the replay, this call was held and recorded on Tuesday, November 10, 2026, at approximately 4:30 p.m. Eastern Time. Since then, the company may have made additional comments related to the topics discussed. I'd now like to turn the call over to Adam Kalbermatten, CEO. Adam, please go ahead.

    Adam Kalbermatten CEO Thank you, Louisa, and good afternoon, everyone. I'll first begin with commentary on this quarter's business highlights before handing the call over to Tom to discuss financial results and our updated guidance. Before diving into the results, I want to make several points. KORU has an incredible opportunity ahead of it, and we are working hard to capture it. I don't want to get ahead of ourselves, but I'd like to note the following. First, we are executing on the core business. As we guided in our Q2 call, our top-line growth slowed in Q3, and we are on track to deliver high teens growth in Q4. We continue to grow our recurrent patient base ahead of the market and have made business profitability improvements, and we are pleased with the results. New initiatives take time, and we are working on some big things that could significantly expand our patient base. We are progressing the business along multiple strategic dimensions, opening new geographies, getting new drugs on label, addressing new indications, and adding new technologies. If we execute on these strategic priorities, the business will inflect.

    Frequently Asked Questions About KRMD

    When is KORU Medical Systems's next earnings date?

    KORU Medical Systems's next earnings report is expected for Mar 10, 2027.

    Did KRMD beat earnings estimates last quarter?

    Yes. KORU Medical Systems reported EPS of $0.02 for the quarter ended Sep 30, 2026, above the -$0.02 estimate, a 200.00% surprise.

    What EPS do analysts expect from KRMD next quarter?

    The consensus EPS estimate for KORU Medical Systems for the quarter ending Dec 31, 2026 is -$0.01 from 6 analysts, with estimates from -$0.01 to $0.00.

    How often does KRMD beat earnings estimates?

    KORU Medical Systems beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +71.44%.